Antiinflammatory effect of BPC 157 on experimental periodontitis in rats.
The pentadecapeptide BPC 157 has been shown to have anti-inflammatory and wound healing effects on multiple target tissues and organs. The purpose of the present study was to investigate the effect of BPC 157 on inflammation and bone resorption in experimental periodontitis in rats. First the acute effect of BPC was tested on gingival blood flow by laser doppler flowmetry. Then periodontitis was produced by a silk ligature placed around the lower left first molar. Rats were treated with BPC 157 (once daily for 12 days) or vehicle. At day 13, the gingivomucosal tissues encircling the molars were removed on both sides. Inflammation was assessed by Evans blue plasma extravasation technique and by histology. Alveolar bone loss was analyzed by microCT. BPC 157 had no effect on gingivomucosal blood flow. Twelve day ligature caused a significantly increased Evans blue extravasation in the gingivomucosal tissue, histological signs of inflammation, and alveolar bone destruction. BPC 157 treatment significantly reduced both plasma extravasation, histological alterations and alveolar bone resorption. In conclusion, systemic application of BPC 157 does not alter blood circulation in healthy gingiva. Chronic application of the peptide has potent antiinflammatory effects on periodontal tissues in ligature induced periodontitis in rats. Taken together, this proof of concept study suggests that BPC 157 may represent a new peptide candidate in the treatment of periodontal disease.
Keremi
B
B
Department of Oral Biology, Semmelweis University, Budapest, Hungary.
Lohinai
Z
Z
Komora
P
P
Duhaj
S
S
Borsi
K
K
Jobbagy-Ovari
G
G
Kallo
K
K
Szekely
A D
AD
Fazekas
A
A
Dobo-Nagy
C
C
Sikiric
P
P
Varga
G
G
D016301:Alveolar Bone Loss / Q000517:prevention & control; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001862:Bone Resorption / Q000000981:diagnostic imaging / Q000517:prevention & control; D002199:Capillary Permeability / Q000187:drug effects; D005881:Gingiva / Q000098:blood supply / Q000187:drug effects / Q000473:pathology; D005891:Gingivitis / Q000473:pathology / Q000517:prevention & control; D006439:Hemodynamics / Q000187:drug effects; D021621:Imaging, Three-Dimensional; D017078:Laser-Doppler Flowmetry; D008297:Male; D008334:Mandible; D008963:Molar; D010446:Peptide Fragments / Q000627:therapeutic use*; D010518:Periodontitis / Q000517:prevention & control*; D011506:Proteins / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D055114:X-Ray Microtomography
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010446:Peptide Fragments; D011506:Proteins; C083833:BPC 157